|

Intranasal Oxytocin (IN-OXT) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Elizabeth Austen Lawson1

Indications

  • Vasopressin Deficiency1
  • Depression1
  • Diabetes1
  • Anxiety1

Boston, Massachusetts1 trial

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

Massachusetts General Hospital, Neuroendocrine Unit

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.